Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
FP08 - Multimodality Management of Advanced Lung Cancer
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters (Featured)
- Track: Multimodality of Advanced Lung Cancer
-
+
FP08.04 - Tumour Spread Through Air Space (STAS) In Lung Metastases
00:00 - 00:00 | Presenter: Alberto Sandri
- Abstract
Loading...
-
+
P14 - Immunotherapy (Phase II/III Trials) - Clinical Trial in Progress
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
-
+
P14.03 - Vibostolimab Plus Pembrolizumab With/Without Docetaxel vs Docetaxel in NSCLC After Platinum Chemotherapy and Immunotherapy
00:00 - 00:00 | Presenter: Solange Peters
- Abstract
Loading...
-
+
P42 - Multimodality of Advanced Lung Cancer - Prognostic Factors
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Multimodality of Advanced Lung Cancer
-
+
P42.01 - Tumor Size is an Independent Prognostic Factor after Pulmonary Metastasectomy
00:00 - 00:00 | Presenter: Simona Sobrero
- Abstract
Loading...
-
+
P45 - Novel Therapeutics and Targeted Therapies - ALK/ROS1/MET
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
-
+
P45.12 - Renal Function Change During Alectinib in ALK Rearranged Non-Small Cell Lung Cancer: A Retrospective Multicentre Analysis
00:00 - 00:00 | Presenter: Chiara Paratore
- Abstract
Loading...
-
+
P59 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Targeted Therapies Biomarkers
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
-
+
P59.20 - Natural History of KRAS Mutant Non-Small-Cell Lung Cancer in the Immunotherapy Era: A Single-Centre Retrospective Study
00:00 - 00:00 | Presenter: Paolo Bironzo
- Abstract
Loading...
-
+
IS08 - Industry Symposium Sponsored by Eli Lilly And Company: Personalizing and Optimizing Treatment for Metastatic NSCLC Patients with EGFR Mutations - Is There More We Can Do?
- 05:45 - 06:45
- 9/10/2021
- Location: Industry Symposium Auditorium via Industry Hub
- Not for CME Credit
- Type: Industry Supported Symposium
- Track: N.A.
-
+
IS08.02 - Is a One Size Fits All Approach Still Appropriate for NSCLC with an EGFR Mutation, Are All Mutations Equal?
05:50 - 06:05 | Presenter: Silvia Novello
- Abstract
No abstract available for this presentation
-
+
MA12 - The Impact of COVID-19 on How We Treat Thoracic Cancer Now and in the Future
- 20:00 - 21:00
- 9/12/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Management of Lung Cancer in the Era of COVID-19
-
+
MA12.07 - Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center
20:40 - 20:45 | Presenter: Maristella Bungaro
- Abstract
Loading...
-
+
OA17 - Multidisciplinary Care of Thoracic Oncology Patients During COVID-19 Pandemic
- 20:00 - 21:00
- 9/12/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Nursing and Allied Health Professionals
- Moderators:Sara McLaughlin-Barrett
-
+
OA17.04 - The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers
20:30 - 20:40 | Presenter: Anne-Marie Baird
- Abstract
Loading...
-
+
PL05 - Plenary 5: Closing Plenary: Immunotherapy and Beyond: Future Directions (Japanese, Mandarin, Spanish Translation Available)
- 21:15 - 22:15
- 9/14/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:Silvia Novello, Thomas E. Stinchcombe
-
+
PL05.01 - CAR T-cell Therapy for Thoracic Cancers
21:15 - 21:27 | Presenter: Prasad Adusumilli
- Abstract
Loading... -
+
PL05.02 - Determinants of Immunotherapy Resistance in Lung Cancer
21:27 - 21:39 | Presenter: Kurt Schalper
- Abstract
No abstract available for this presentation
-
+
PL05.03 - Radiation/IO Synergy/Evolving Technology
21:39 - 21:51 | Presenter: Ken Harada
- Abstract
No abstract available for this presentation
-
+
PL05.04 - IO in the Surgical Resectable Patient
21:51 - 22:03 | Presenter: Jamie Chaft
- Abstract
No abstract available for this presentation
-
+
PL05.05 - Live Discussion with Speakers
22:03 - 22:13
- Abstract
No abstract available for this presentation
-
+
PL05.06 - Closing Remarks
22:13 - 22:15
- Abstract
No abstract available for this presentation
